Literature DB >> 8380129

Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene.

J E Hulla1, Z Y Chen, D L Eaton.   

Abstract

The weight of accumulated evidence suggests a role for the p53 tumor suppressor gene in the development of human hepatocellular carcinoma (HCC). Most striking is an apparent mutational specificity at codon 249 of the human gene. Aflatoxin B1 (AFB) is a liver-specific carcinogen which causes G to T substitutions. This transversion was detected at codon 249 in about 50% of the analyzed HCC tumors from African and Asian patients. In these geographic regions aflatoxin exposure and hepatitis B viral infection are risk factors for HCC. In contrast to the human data, no mutations at codon 249 were detected in AFB-induced tumors from non-human primates. We have analyzed the p53 gene at the site corresponding to codon 249 of the human gene in AFB-induced preneoplastic hepatic nodules from rats. No mutations were detected in the tissues examined. Our data suggest that, at least in the rat, AFB exposure alone may not be sufficient for the specificity of p53 mutations observed in HCC.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8380129

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

Review 1.  Mode of action-based risk assessment of genotoxic carcinogens.

Authors:  Andrea Hartwig; Michael Arand; Bernd Epe; Sabine Guth; Gunnar Jahnke; Alfonso Lampen; Hans-Jörg Martus; Bernhard Monien; Ivonne M C M Rietjens; Simone Schmitz-Spanke; Gerlinde Schriever-Schwemmer; Pablo Steinberg; Gerhard Eisenbrand
Journal:  Arch Toxicol       Date:  2020-06-15       Impact factor: 5.153

Review 2.  New insights in hepatocellular carcinoma: from bench to bedside.

Authors:  Samuele De Minicis; Marco Marzioni; Antonio Benedetti; Gianluca Svegliati-Baroni
Journal:  Ann Transl Med       Date:  2013-07

3.  Immunohistochemical analysis of p53 protein overexpression in liver cell dysplasia and in hepatocellular carcinoma.

Authors:  M Zhao; N X Zhang; J A Laissue; A Zimmermann
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Diminished expression of phosphatidylethanolamine N-methyltransferase 2 during hepatocarcinogenesis.

Authors:  L Tessitore; I Dianzani; Z Cui; D E Vance
Journal:  Biochem J       Date:  1999-01-01       Impact factor: 3.857

Review 5.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

6.  Potential role of p53 mutation in chemical hepatocarcinogenesis of rats.

Authors:  Wei-Guo Deng; Yan Fu; Yu-Lin Li; Toshihiro Sugiyama
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

7.  Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.

Authors:  Naoshi Nishida; Ajay Goel
Journal:  Curr Genomics       Date:  2011-04       Impact factor: 2.236

8.  Aflatoxin B1 DNA-Adducts in Hepatocellular Carcinoma from a Low Exposure Area.

Authors:  Laura Gramantieri; Federica Gnudi; Francesco Vasuri; Daniele Mandrioli; Francesca Fornari; Francesco Tovoli; Fabrizia Suzzi; Andrea Vornoli; Antonia D'Errico; Fabio Piscaglia; Catia Giovannini
Journal:  Nutrients       Date:  2022-04-15       Impact factor: 6.706

Review 9.  Evaluation of Polymer Nanoformulations in Hepatoma Therapy by Established Rodent Models.

Authors:  Qilong Wang; Ping Zhang; Zhongmin Li; Xiangru Feng; Chengyue Lv; Huaiyu Zhang; Haihua Xiao; Jianxun Ding; Xuesi Chen
Journal:  Theranostics       Date:  2019-02-20       Impact factor: 11.556

Review 10.  The genetics of human cancer: implications for ecotoxicology.

Authors:  G McMahon
Journal:  Environ Health Perspect       Date:  1994-12       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.